P3.02c-039 Endocrinological Side-Effects of Nivolumab in Advanced Non-Small Cell Lung Cancer von Rossi, Giovanni, Albertelli, Manuela, Nazzari, Elena, Rijavec, Erka, Genova, Carlo, Barletta, Giulia, Biello, Federica, Maggioni, Claudia, Dal Bello, Maria Giovanna, Ferone, Diego, Grossi, Francesco

Volltext

P3.02c-039 Endocrinological Side-Effects of Nivolumab in Advanced Non-Small Cell Lung Cancer: Topic: IT von Rossi, Giovanni, Albertelli, Manuela, Nazzari, Elena, Rijavec, Erka, Genova, Carlo, Barletta, Giulia, Biello, Federica, Maggioni, Claudia, Dal Bello, Maria Giovanna, Ferone, Diego, Grossi, Francesco

Volltext

P2.01-067 The Relevance of CEA and CYFRA21-1 as Predictive Factors in Nivolumab Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: Topic: Immune Mechanisms in Thoracic C... von Dal Bello, Maria Giovanna, Filiberti, Rosangela, Rijavec, Erka, Genova, Carlo, Barletta, Giulia, Rossi, Giovanni, Biello, Federica, Distefano, Roberta, Orengo, Anna Maria, Alama, Angela, Coco, Simona, Vanni, Irene, Mussap, Michele, Grossi, Francesco

Volltext

P2.01-067 The Relevance of CEA and CYFRA21-1 as Predictive Factors in Nivolumab Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients von Dal Bello, Maria Giovanna, Filiberti, Rosangela, Rijavec, Erka, Genova, Carlo, Barletta, Giulia, Rossi, Giovanni, Biello, Federica, Distefano, Roberta, Orengo, Anna Maria, Alama, Angela, Coco, Simona, Vanni, Irene, Mussap, Michele, Grossi, Francesco

Volltext

MA10.09 Comparison between CT Scan Evaluation Criteria and PERCIST for Evaluation of Immune Check-Point Inhibitors Response von Rossi, Giovanni, Genova, Carlo, Morbelli, Silvia, Rijavec, Erka, Barletta, Giulia, Biello, Federica, Maggioni, Claudia, Mennella, Simone, Dal Bello, Maria Giovanna, Distefano, Roberta, Bauckneht, Matteo, Cittadini, Giuseppe, Merlo, Franco, Sambuceti, Gianmario, Grossi, Francesco

Volltext